成人单叶主动脉瓣治疗中Ross手术与瓣膜修复的比较
本研究比较了成人单叶主动脉瓣患者行瓣膜修复与Ross手术的中期结果。10年生存率两组无显著差异,但Ross组免于再干预率显著优于修复组。作者认为修复可视为年轻患者向Ross手术的桥接。
要点
- 成人单叶主动脉瓣修复术后10年免于再干预率为80%,Ross手术为98%,差异显著。
- 两组10年生存率分别为修复组97%、Ross组95%,无显著差异。
- 作者认为瓣膜修复可考虑作为年轻患者向Ross手术的桥接。
核心结论
- 单叶主动脉瓣的理想治疗仍存争议。
- 瓣膜修复可考虑作为向肺动脉自体移植替换的桥接,至少在较年轻患者中如此。
- 合适的替换与修复时机需进一步研究。
研究设计与样本
- 研究纳入1998年12月至2022年4月期间共345例接受单叶主动脉瓣治疗的患者,排除年龄<18岁(n=84)或>54岁(n=3)者。
- 手术指征包括主动脉瓣反流(n=104)、主动脉瓣狭窄(n=45)、混合性病变(n=103)和心内膜炎(n=6)。
- 51例患者存在根部扩张(>43 mm)合并主动脉瓣反流(修复组n=23;Ross组n=28)。
- 平均随访5.9年(标准差5年),范围0.1至22.3年。
主要发现
- 共发生1例早期死亡和3例晚期死亡;47例患者需要再干预。
- 10年生存率Ross组为95%,瓣膜修复组为97%(P=0.769)。
- 10年免于再干预率Ross组为98%,瓣膜修复组为80%(P=0.012)。
- 受试者工作特征曲线分析显示,年龄<26岁的患者有耐久性更好的趋势。
临床怎么用
- 作者认为瓣膜修复可考虑作为向肺动脉自体移植替换的桥接,至少在较年轻患者中如此。
- 作者指出合适的替换与修复时机需进一步研究。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Aortic stenosis or regurgitation in patients with a unicuspid valve morphology requires interventions early in life. We have performed either primary valve repair or the Ross procedure. The goal of this study was to compare the midterm results of repair and pulmonary autograft replacement. METHODS: Between December 1998 and April 2022, a total of 345 patients (77% male; mean age 34 ± 9.7 years) underwent treatment of a unicuspid aortic valve. Patients were excluded if they were <18 years (n = 84) or >54 years (n = 3) at the time of the operation. The remaining cohort was divided into 2 groups: 167 (64%) patients underwent valve repair; 91 (36%) patients underwent pulmonary autograft replacement.The indications for surgery were aortic regurgitation (n = 104), aortic stenosis (n = 45), combined disease (n = 103) and endocarditis (n = 6). Fifty-one patients had root dilatation (>43 mm) with aortic regurgitation (repair n = 23; Ross n = 28). Mean follow-up was 5.9 years (SD: 5 years) [range 0.1-22.3 years]. RESULTS: There were 1 early and 3 late deaths; 47 patients required reintervention. Survival at 10 years was 95% in the Ross group and 97% after valve repair (P = 0.769). Freedom from reintervention at 10 years was 98% in the Ross group and 80% after valve repair (P = 0.012). A receiver operating characteristics curve analysis showed a trend towards better durability in patients < 26 years. CONCLUSIONS: The ideal treatment of the unicuspid aortic valve remains debatable. Repair of a unicuspid valve can be considered a bridge to pulmonary autograft replacement, at least in younger patients. The appropriate times to replace and to repair require further investigation.
引用
- Abeln KB, Matsushima S, Ehrlich T, et al. The Ross procedure versus repair for treatment of a unicuspid aortic valve in adults†. Eur J Cardiothorac Surg. 2023. PMID: 36961343. doi:10.1093/ejcts/ezad118
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。